Journal articles on the topic 'Chylomicron remnant'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Chylomicron remnant.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Bowler, A., T. G. Redgrave, and J. C. L. Mamo. "Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor." Biochemical Journal 276, no. 2 (June 1, 1991): 381–86. http://dx.doi.org/10.1042/bj2760381.
Full textMansbach, C. M., and R. F. Dowell. "Role of the intestine in chylomicron remnant clearance." American Journal of Physiology-Gastrointestinal and Liver Physiology 269, no. 1 (July 1, 1995): G144—G152. http://dx.doi.org/10.1152/ajpgi.1995.269.1.g144.
Full textYU, Kenneth C. W., and John C. L. MAMO. "Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis." Clinical Science 98, no. 2 (January 11, 2000): 183–92. http://dx.doi.org/10.1042/cs0980183.
Full textSoued, M., and C. M. Mansbach. "Chylomicron remnant uptake by enterocytes is receptor dependent." American Journal of Physiology-Gastrointestinal and Liver Physiology 270, no. 1 (January 1, 1996): G203—G212. http://dx.doi.org/10.1152/ajpgi.1996.270.1.g203.
Full textIrawati, Deasy, John C. L. Mamo, Karin M. Slivkoff-Clark, Mario J. Soares, and Anthony P. James. "Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk." British Journal of Nutrition 117, no. 3 (February 14, 2017): 403–12. http://dx.doi.org/10.1017/s0007114517000150.
Full textTsai, Michael Y., Angeliki Georgopoulos, James D. Otvos, Jose M. Ordovas, Naomi Q. Hanson, James M. Peacock, and Donna K. Arnett. "Comparison of Ultracentrifugation and Nuclear Magnetic Resonance Spectroscopy in the Quantification of Triglyceride-Rich Lipoproteins after an Oral Fat Load." Clinical Chemistry 50, no. 7 (July 1, 2004): 1201–4. http://dx.doi.org/10.1373/clinchem.2004.032938.
Full textvan Dijk, M. C. M., G. J. Ziere, W. Boers, C. Linthorst, M. K. Bijsterbosch, and T. J. C. van Berkel. "Recognition of chylomicron remnants and β-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver α2-macroglobulin-recognition site." Biochemical Journal 279, no. 3 (November 1, 1991): 863–70. http://dx.doi.org/10.1042/bj2790863.
Full textBorensztajn, J., and T. J. Kotlar. "Phospholipids as modulators of hepatic recognition of chylomicron remnants. Observations with emulsified lipoprotein lipids." Biochemical Journal 269, no. 2 (July 15, 1990): 539–42. http://dx.doi.org/10.1042/bj2690539.
Full textELSEGOOD, Caryn L., Sebely PAL, Paul D. ROACH, and John C. L. MAMO. "Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins." Clinical Science 101, no. 2 (June 18, 2001): 111–19. http://dx.doi.org/10.1042/cs1010111.
Full textMahley, Robert W., and M. Mahmood Hussain. "Chylomicron and chylomicron remnant catabolism." Current Opinion in Lipidology 2, no. 3 (June 1991): 170–76. http://dx.doi.org/10.1097/00041433-199106000-00005.
Full textWindler, E. E. T., J. Greeve, W. H. Daerr, and H. Greten. "Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal." Biochemical Journal 252, no. 2 (June 1, 1988): 553–61. http://dx.doi.org/10.1042/bj2520553.
Full textKarpe, F., T. Olivecrona, A. Hamsten, and M. Hultin. "Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants." Journal of Lipid Research 38, no. 5 (May 1997): 949–61. http://dx.doi.org/10.1016/s0022-2275(20)37219-9.
Full textLambert, Marc S., Michael A. Avella, Kathleen M. Botham, and Peter A. Mayes. "Comparison of short- and long-term effects of different dietary fats on the hepatic uptake and metabolism of chylomicron remnants in rats." British Journal of Nutrition 79, no. 2 (February 1998): 203–11. http://dx.doi.org/10.1079/bjn19980032.
Full textWATTS, G. F., D. C. F. CHAN, P. H. R. BARRETT, I. J. MARTINS, and T. G. REDGRAVE. "Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity." Clinical Science 101, no. 6 (November 20, 2001): 683–90. http://dx.doi.org/10.1042/cs1010683.
Full textSakr, Sana W., N. Attia, M. Haourigui, J. L. Paul, T. Soni, D. Vacher, and A. Girard-Globa. "Fatty acid composition of an oral load affects chylomicron size in human subjects." British Journal of Nutrition 77, no. 1 (January 1997): 19–31. http://dx.doi.org/10.1017/s0007114500002853.
Full textKarpe, F., A. S. Bickerton, L. Hodson, B. A. Fielding, G. D. Tan, and K. N. Frayn. "Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation." Biochemical Society Transactions 35, no. 3 (May 22, 2007): 472–76. http://dx.doi.org/10.1042/bst0350472.
Full textWilliams, Christine M. "Dietary interventions affecting chylomicron and chylomicron remnant clearance." Atherosclerosis 141 (December 1998): S87—S92. http://dx.doi.org/10.1016/s0021-9150(98)00224-x.
Full textLambert, M. S., K. M. Botham, and P. A. Mayes. "Variations in composition of dietary fats affect hepatic uptake and metabolism of chylomicron remnants." Biochemical Journal 310, no. 3 (September 15, 1995): 845–52. http://dx.doi.org/10.1042/bj3100845.
Full textMamo, J. C. L., C. L. Elsegood, K. Yu, S. Schurmann, T. G. Redgrave, and Y. Umeda. "Chylomicron remnant metabolism by macrophages." Atherosclerosis 109, no. 1-2 (September 1994): 197–98. http://dx.doi.org/10.1016/0021-9150(94)93795-8.
Full textBernik, Márcia MS, Joel C. Heimann, Edna R. Nakandakare, Patrícia M. Cazita, Valéria S. Nunes, Jussara C. Rocha, Mônica QTS Neves, and Eder CR Quintão. "Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive subjects." Canadian Journal of Physiology and Pharmacology 83, no. 7 (July 1, 2005): 617–23. http://dx.doi.org/10.1139/y05-051.
Full textSultan, F., D. Lagrange, X. Le Liepvre, and S. Griglio. "Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase." Biochemical Journal 258, no. 2 (March 1, 1989): 587–94. http://dx.doi.org/10.1042/bj2580587.
Full textStaprans, I., X. M. Pan, J. H. Rapp, and K. R. Feingold. "Chylomicron and Chylomicron Remnant Metabolism in STZ-Induced Diabetic Rats." Diabetes 41, no. 3 (March 1, 1992): 325–33. http://dx.doi.org/10.2337/diab.41.3.325.
Full textStaprans, I., X. M. Pan, J. H. Rapp, and K. R. Feingold. "Chylomicron and chylomicron remnant metabolism in STZ-induced diabetic rats." Diabetes 41, no. 3 (March 1, 1992): 325–33. http://dx.doi.org/10.2337/diabetes.41.3.325.
Full textLippiello, P. M., P. J. Sisson, and M. Waite. "The uptake and metabolism of chylomicron-remnant lipids by rat liver parenchymal and non-parenchymal cells in vitro." Biochemical Journal 232, no. 2 (December 1, 1985): 395–401. http://dx.doi.org/10.1042/bj2320395.
Full textBravo, E., and M. Napolitano. "Mechanisms involved in chylomicron remnant lipid uptake by macrophages." Biochemical Society Transactions 35, no. 3 (May 22, 2007): 459–63. http://dx.doi.org/10.1042/bst0350459.
Full textWillnow, T. E. "Mechanisms of Hepatic Chylomicron Remnant Clearance." Diabetic Medicine 14, S3 (August 1997): S75—S80. http://dx.doi.org/10.1002/(sici)1096-9136(199708)14:3+
Willnow, T. E. "Mechanisms of Hepatic Chylomicron Remnant Clearance." Diabetic Medicine 14, S3 (August 1997): S75—S80. http://dx.doi.org/10.1002/(sici)1096-9136(199708)14:3+
Pan, X. M., I. Staprans, D. A. Hardman, and J. H. Rapp. "Exposure to cigarette smoke delays the plasma clearance of chylomicrons and chylomicron remnants in rats." American Journal of Physiology-Gastrointestinal and Liver Physiology 273, no. 1 (July 1, 1997): G158—G163. http://dx.doi.org/10.1152/ajpgi.1997.273.1.g158.
Full textHussain, M. M., R. W. Mahley, J. K. Boyles, M. Fainaru, W. J. Brecht, and P. A. Lindquist. "Chylomicron-Chylomicron Remnant Clearance by Liver and Bone Marrow in Rabbits." Journal of Biological Chemistry 264, no. 16 (June 1989): 9571–82. http://dx.doi.org/10.1016/s0021-9258(18)60570-8.
Full textKaysen, G. A., L. Mehendru, X. M. Pan, and I. Staprans. "Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis." American Journal of Physiology-Renal Physiology 263, no. 2 (August 1, 1992): F335—F341. http://dx.doi.org/10.1152/ajprenal.1992.263.2.f335.
Full textGOULTER, Andrew B., Michael A. AVELLA, Jonathan ELLIOTT, and Kathleen M. BOTHAM. "Chylomicron-remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries." Clinical Science 103, no. 5 (October 3, 2002): 451–60. http://dx.doi.org/10.1042/cs1030451.
Full textBOKU, Akitoshi, Atsuko YANADA, Tomio ONUMA, Masahiro TSUTSUI, Shigeru OCHIAI, and Kazuo TAKEBE. "Abnormalities of Chylomicron Remnant Metabolism in Diabetics." Journal of Japan Atherosclerosis Society 16, no. 1 (1988): 59–62. http://dx.doi.org/10.5551/jat1973.16.1_59.
Full textCooper, Allen D., and David Coleman. "Chylomicron remnant and asialoglycoprotein metabolism are independent." Lipids 20, no. 10 (October 1985): 664–67. http://dx.doi.org/10.1007/bf02534384.
Full textWillnow, T. E., S. Ishibashi, and J. Herz. "Dissection of the chylomicron remnant clearance pathway." Atherosclerosis 109, no. 1-2 (September 1994): 81–82. http://dx.doi.org/10.1016/0021-9150(94)93342-1.
Full textRebholz, Sandra L., Katie T. Burke, Qing Yang, Patrick Tso, and Laura A. Woollett. "Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta." American Journal of Physiology-Endocrinology and Metabolism 301, no. 2 (August 2011): E416—E425. http://dx.doi.org/10.1152/ajpendo.00619.2010.
Full textCastro Cabezas, Manuel, Tjerk W. A. de Bruin, Luciënne A. W. Kock, Wouter Kortlandt, Margreet Van Linde-Sibenius Trip, Hans Jansen, and D. Willem Erkelens. "Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion." Metabolism 42, no. 4 (April 1993): 497–503. http://dx.doi.org/10.1016/0026-0495(93)90109-2.
Full textHuettinger, Manfred, Helmut Retzek, Martina Eder, and Hans Goldenberg. "Characteristics of chylomicron remnant uptake into rat liver." Clinical Biochemistry 21, no. 2 (April 1988): 87–92. http://dx.doi.org/10.1016/s0009-9120(88)80093-6.
Full textCabezas, M. C., T. W. de Bruin, H. Jansen, L. A. Kock, W. Kortlandt, and D. W. Erkelens. "Impaired chylomicron remnant clearance in familial combined hyperlipidemia." Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 13, no. 6 (June 1993): 804–14. http://dx.doi.org/10.1161/01.atv.13.6.804.
Full textKAWASAKI, SATORU, TAKAHIRO TANIGUCHI, YOSHIO FUJIOKA, AKIHIRO TAKAHASHI, TOMOSABURO TAKAHASHI, KOJI DOMOTO, MASAKO TAGUCHI, YUICHI ISHIKAWA, and MITSUHIRO YOKOYAMA. "Chylomicron Remnant Induces Apoptosis in Vascular Endothelial Cells." Annals of the New York Academy of Sciences 902, no. 1 (January 25, 2006): 336–41. http://dx.doi.org/10.1111/j.1749-6632.2000.tb06334.x.
Full textWindler, E., J. Greeve, S. Ja¨ckle, F. Rinninger, and H. Greten. "Mechanisms regulating hepatic chylomicron remnant uptake and metabolism." Atherosclerosis 109, no. 1-2 (September 1994): 173–74. http://dx.doi.org/10.1016/0021-9150(94)93699-4.
Full textZilversmit, D. B. "Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins." Clinical Chemistry 41, no. 1 (January 1, 1995): 153–58. http://dx.doi.org/10.1093/clinchem/41.1.153.
Full textSzanto, A., S. Balasubramaniam, P. D. Roach, and P. J. Nestel. "Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism." Biochemical Journal 288, no. 3 (December 15, 1992): 791–94. http://dx.doi.org/10.1042/bj2880791.
Full textChan, Dick C., Gerald F. Watts, P. Hugh Barrett, John CL Mamo, and Trevor G. Redgrave. "Markers of Triglyceride-rich Lipoprotein Remnant Metabolism in Visceral Obesity." Clinical Chemistry 48, no. 2 (February 1, 2002): 278–83. http://dx.doi.org/10.1093/clinchem/48.2.278.
Full textLopez-Soldado, I., M. Avella, and K. M. Botham. "Comparison of the effects of dietary saturated, mono-unsaturated and polyunsaturated fatty acids on very-low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnant-like particles." Biochemical Society Transactions 35, no. 3 (May 22, 2007): 440–41. http://dx.doi.org/10.1042/bst0350440.
Full textGOULTER, Andrew B., Michael AVELLA, Kathleen M. BOTHAM, and Jonathan ELLIOTT. "Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells." Clinical Science 105, no. 3 (September 1, 2003): 363–71. http://dx.doi.org/10.1042/cs20030039.
Full textNapolitano, Mariarosaria, Howard S. Kruth, and Elena Bravo. "Phospholipase A2 Mediates Apolipoprotein-Independent Uptake of Chylomicron Remnant-Like Particles by Human Macrophages." International Journal of Vascular Medicine 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/501954.
Full textVan Berkel, Th J. C., M. C. M. Van Dijk, G. J. Ziere, M. N. Pieters, and J. K. Kruyt. "Chylomicron-remnant recognition and biliary secretion of dietary cholesterol." Atherosclerosis 109, no. 1-2 (September 1994): 174. http://dx.doi.org/10.1016/0021-9150(94)93700-1.
Full textEvans, M., Y. Berhane, K. M. Botham, J. Elliott, and C. P. D. Wheeler-Jones. "Chylomicron-remnant-like particles modify production of vasoactive mediators by endothelial cells." Biochemical Society Transactions 32, no. 1 (February 1, 2004): 110–12. http://dx.doi.org/10.1042/bst0320110.
Full textRedgrave, T. G., G. F. Watts, I. J. Martins, P. H. R. Barrett, J. C. L. Mamo, S. B. Dimmitt, and A. D. Marais. "Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test." Journal of Lipid Research 42, no. 5 (May 2001): 710–15. http://dx.doi.org/10.1016/s0022-2275(20)31632-1.
Full textNAPOLITANO, Mariarosaria, Kelly V. BATT, Michael AVELLA, Elena BRAVO, and Kathleen M. BOTHAM. "Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidized chylomicron-remnant-like particles by oestrogen." Clinical Science 101, no. 4 (September 14, 2001): 403–13. http://dx.doi.org/10.1042/cs1010403.
Full text